Scopia Capital to inject up to $60mn into struggling R&Q

London-listed R&Q has hailed a deal with one of its new shareholders to inject $50mn+ into the business as a significant step in splitting its struggling legacy arm from its fast-growing MGA fronting business Accredited.

 

Want to read this article?

 

For details on how to subscribe or for all commercial opportunities, including advertising, please contact:

Andy Stone

Sales manager

+44 (0) 77 4160 9204

andy.stone@thomsonreuters.com

    Ricky Lamey

    Business development executive

    ricky.lamey@thomsonreuters.com